Chinese private equity firm Legend Capital has joined China Renaissance’s healthcare fund to co-lead an investment worth nearly RMB2 billion (US$293 million) in Chinese Diagnostics Medical Corporation. Legend Capital contributed about US$100 billion.  Other investors including Matrix Partners, Ping An Ventures, High Light Capital, Zhongjin Kangrui Healthcare Industrial Fund, and Shanghai Free Trade Zone Equity Fund (FTZ Fund) also participated in the round, according to Legend Capital’s announcement. Founded in 1999, Chinese Diagnostics Medical Corporation specializes in the design and …

Legend Capital Joins China Renaissance To Lead $293M Investment In Chinese Diagnostics Medical Corporation appeared first on China Money Network.